Calculus CEO John Glencross has been featured in a City AM article discussing the upcoming Autumn Budget and the outcome of the Patient Capital Review.
“In the government’s Patient Capital Review earlier this year, concerns were raised that VCTs and EISs – which give investors tax breaks to combat the perceived risk of backing young startups – were being used outside their remit. “The Treasury feels there is far too much VCT money being used to capture the tax breaks without it being capital at risk,” said John Glencross, chief executive of Calculus Capital, whose firm has been involved in discussions with the government throughout the Patient Capital Review.”
To read the article in full, click here.
John will discuss the Budget and the outcome of the Patient Capital Review in a free Webinar on 28 November. Register via this link.